147 related articles for article (PubMed ID: 38059831)
1. Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study.
Mezzacappa C; Rossi R; Jaffe A; Taddei TH; Strazzabosco M
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):270-278. PubMed ID: 38059831
[TBL] [Abstract][Full Text] [Related]
2. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
[TBL] [Abstract][Full Text] [Related]
3. Local geographic variation in chronic liver disease and hepatocellular carcinoma: contributions of socioeconomic deprivation, alcohol retail outlets, and lifestyle.
Major JM; Sargent JD; Graubard BI; Carlos HA; Hollenbeck AR; Altekruse SF; Freedman ND; McGlynn KA
Ann Epidemiol; 2014 Feb; 24(2):104-10. PubMed ID: 24332863
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status and hepatocellular carcinoma in the United States.
Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949
[TBL] [Abstract][Full Text] [Related]
5. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort study.
Anyiwe K; Qiao Y; De P; Yoshida EM; Earle CC; Thein HH
Liver Int; 2016 Jun; 36(6):902-10. PubMed ID: 26455359
[TBL] [Abstract][Full Text] [Related]
6. Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States.
VoPham T; Bertrand KA; Yuan JM; Tamimi RM; Hart JE; Laden F
Environ Health; 2017 Aug; 16(1):89. PubMed ID: 28821245
[TBL] [Abstract][Full Text] [Related]
7. Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas.
Oluyomi AO; El-Serag HB; Olayode A; Thrift AP
Clin Gastroenterol Hepatol; 2023 May; 21(5):1314-1322.e5. PubMed ID: 35933074
[TBL] [Abstract][Full Text] [Related]
8. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
Zhang X; El-Serag HB; Thrift AP
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
[TBL] [Abstract][Full Text] [Related]
9. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
Davila JA; Petersena NJ; Nelson HA; El-Serag HB
J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma - United States, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
Rich NE; Yopp AC; Singal AG; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
[TBL] [Abstract][Full Text] [Related]
13. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.
Sahasrabuddhe VV; Shiels MS; McGlynn KA; Engels EA
Cancer; 2012 Dec; 118(24):6226-33. PubMed ID: 22736272
[TBL] [Abstract][Full Text] [Related]
14. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
15. Geographic disparities and determinants of COVID-19 incidence risk in the greater St. Louis Area, Missouri (United States).
Das P; Igoe M; Lenhart S; Luong L; Lanzas C; Lloyd AL; Odoi A
PLoS One; 2022; 17(9):e0274899. PubMed ID: 36170339
[TBL] [Abstract][Full Text] [Related]
16. Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality.
Persson EC; Schwartz LM; Park Y; Trabert B; Hollenbeck AR; Graubard BI; Freedman ND; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):415-21. PubMed ID: 23307533
[TBL] [Abstract][Full Text] [Related]
17. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.
Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J
Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200
[TBL] [Abstract][Full Text] [Related]
18. Patients with hepatocellular carcinoma from more rural and lower-income households have more advanced tumor stage at diagnosis and significantly higher mortality.
Wong RJ; Kim D; Ahmed A; Singal AK
Cancer; 2021 Jan; 127(1):45-55. PubMed ID: 33103243
[TBL] [Abstract][Full Text] [Related]
19. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
[TBL] [Abstract][Full Text] [Related]
20. Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
Int J Cancer; 2007 Oct; 121(7):1624-6. PubMed ID: 17557292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
